Skip to content

mRNA Manufacturing Raw Material Strategy After Capacity Shifts

mRNA manufacturing raw material strategy with IVT enzymes capping DNase cleanup and QC workflow

Recent mRNA manufacturing capacity shifts highlight why raw material strategy matters. This guide covers GMP-grade IVT enzymes, capping, DNase cleanup, QC and OEM planning for resilient RNA programs.

Residual DNA Testing for Gene Therapy Manufacturing: A Practical QC Guide

Residual DNA testing for gene therapy manufacturing practical QC guide with qPCR analysis, viral vector and DNA visualization

A practical guide to residual DNA testing in gene therapy and biomanufacturing QC, covering method selection, sample prep, HCP/HCD risk, and supplier considerations.

Meet Biori at ASGCT 2026 Boston,MA-Booth 1511

Biori at ASGCT 2026 Booth 1511 cover highlighting HCD HCP testing, universal nuclease and custom kit development for cell and gene therapy QC

Meet Biori at ASGCT 2026, Booth No. 1511, to discuss HCD/HCP testing solutions, universal nuclease, and customized kit development services for CGT manufacturing and QC.

mRNA Bird Flu Vaccine IVT Enzymes and QC Guide

mRNA bird flu vaccine IVT enzymes capping and quality control illustration

Explore the mRNA bird flu vaccine workflow, from GMP-grade IVT enzymes and capping to residual DNA and HCP testing for biopharma QC.